Glucose monitoring by means of an intravenous microdialysis catheter technique

Diabetes Technology and Therapeutics

Volumn 12, Issue 4, 2010, Pages 291-295

  Hage, Camilla ^a   Mellbin, Linda ^a   Rydén, Lars ^a   Wernerman, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIALYSIS CATHETER; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; INTRAVENOUS CATHETER; MALE; MICRODIALYSIS; MICRODIALYSIS CATHETER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CATHETERIZATION, PERIPHERAL; CORONARY CARE UNITS; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED;

EID: 77949362504     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0150     Document Type: Article

References (12)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778.
2. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
3. Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L; DIGAMI 2 investigators: Prognostic implications of hypoglycemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes. A report from the DIGAMI 2 trial. Heart 2009;95:721-727.
4. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661.
5. Cheung NW, Wong VW, McLean M: The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006;29:765-770.
6. McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, Leppert R, Foss A, Cook D: Lowering of glucose in critical care: a randomized pilot trial. J Crit Care 2007;22:112-118; discussion 118-119.
7. Aragon D: Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006;15:370-377.
8. Hage C, Norhammar A, Grip L, Malmberg K, Sarkar NM, Svane B, Rydén L: Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study. Diabetes Vasc Dis Res 2009;6:71-79.
9. Lindsay J, Sharma AK, Canos D, Nandalur M, Pinnow E, Apple S, Ruotolo G, Wijetunga M, Waksman R: Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C. Cardiovasc Revasc Med 2007;8:15-20.
10. Mattsson P, Rooyackers O, Wernerman J: The impact of membrane length and dialysis pump velocity on accuracy during intravenous microdialysis. Intensive Care Med 2009; 35:121.
11. International Organization for Standardization: In Vitro Diagnostic Test Systems: Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. ISO publication 15197. Geneva: International Organization for Standardization, 2003.
12. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.